CONFERENCE DAY 1 - MONDAY 28 MAY 2018

09:00 WELCOME ADDRESS

• Mr René Jenny, President, European Healthcare Distribution Association (GIRP)

• Mr Seamus Feely, Secretary General, Pharmaceutical Distributors Federation (PDF)

09:30 OPENING ADDRESS Improved healthcare, better medicines

• Mr Simon Harris, Minister for Health, Government of Ireland

10:00 KEYNOTE ADDRESS

'Digital' Healthcare - a perspective from a Pharma company

• Dr. Severin Schwan, Chief Executive Officer, Roche

10:30 KEYNOTE ADDRESS Open economy for globalised business

• Mr Danny McCoy, Chief Executive Officer, Irish Business and Employers Confederation (Ibec)

11:00 COFFEE BREAK

11:30 KEYNOTE ADDRESSES Available healthcare—The role of the agencies

The European Medicines Agency and national agencies have a great role to play in facilitating innovation

for healthcare stakeholders. How do they promote new practices and models? What are the processes in place? What are their main focus and priorities? How can innovation assist in improving treatment out-

comes for patients? What is the agencies role in ensuring availability of medicines?

• Dr. Christa Wirthumer-Hoche, Head, Austrian Medicines and Medical Devices Agency

& Chair, European Medicines Agency (EMA) Management Committee • Dr. Lorraine Nolan, Chief Executive, Health Products Regulatory Authority (HPRA)

12:30 LUNCH

13:30 Building efficient and resilient healthcare systems Personalised healthcare is transforming our practices and promises to optimize the delivery of effective treatment, thus contributing to a more efficient and resilient healthcare system. How does it impact the

healthcare value chain? Does it affect the rising demand for value-based outcome?

Moderator: Mr Peter O’Donnell, Journalist

• Mr Paul Reilly, Managing Director, United Drug

• Mr Owen McKeon, Country Manager, Mylan Ireland

• Mr Darragh O’Loughlin, Secretary General, Irish Pharmacy Union (IPU)

• Mr Yannis Natsis, Policy Manager for Universal Access and Affordable Medicines, European Public

Health Alliance (EPHA)

European Healthcare Distribution Association

Groupement International de la Répartition Pharmaceutique

T: +32 2 777 99 77 E: girp@girp.eu

F: +32 2 770 36 01 W: www.girp.eu

14:30 INVESTING IN HEALTHCARE Keynote: Pharmaceuticals - from humble beginnings to global significance

• Mr Tommy Fanning, Global Head of Biopharmaceuticals & Food, State agency of the Department of Jobs,

Enterprise and Innovation - IDA Ireland

Panel: Working together for improved outcomes All stakeholders along the supply chain are working towards one main goal: providing care to the patient in a

safe and efficient manner. How can we all pull together to overcome operational and supply chain management challenges in value chain creation? How can new technologies serve the purpose of better

cooperation for improved outcomes?

Moderator: Dr. Roger Sorel, Vice President, GIRP

• Dr. Henry Colm, Interim Chief Clinical Officer, Irish Health Service Executive (HSE)

• Mr Gerard Rabbette, Chief Executive Officer, Uniphar Plc

• Mr Ryan Quigley, Regional Vice President Europe North and Immunology & HCV lead WE&C, AbbVie

• Mr Boris Azais, Director Public Policy Europe Canada, MSD

16:00 COFFEE BREAK

16:30 GLOBAL INSIGHTS INTO OUR HEALTHCARE WORLD Keynote: The power of real-world insight in healthcare

• Mr Doug Long, Vice President Industry Relations, IQVIA

Panel: Recent market trends in healthcare This panel, composed of top executives, will reflect upon the overarching trends and developments in the

international healthcare distribution and services sector at present and in the foreseeable future.

Moderator: Mr Doug Long, Vice President Industry Relations, IQVIA

• Mr Brian S. Tyler, Chairman of the Management Board, McKesson Europe

• Mr Tony Mauro, Chief Commercial Officer, Mylan

• Mr Frank Grosse-Natrop, Executive Board Member Operations / Logistics, PHOENIX Group

18:00 END OF CONFERENCE DAY 1

European Healthcare Distribution Association

Groupement International de la Répartition Pharmaceutique

T: +32 2 777 99 77 E: girp@girp.eu

F: +32 2 770 36 01 W: www.girp.eu

CONFERENCE DAY 2 - TUESDAY 29 MAY 2018

09:00 KEYNOTE ADDRESS Transformative power of technologies in healthcare

• Mr Per Troein, Vice President Strategic Partners, IQVIA

09:30 Connecting the dots from on-boarding partners to end-users Hear best practices from professionals and expert service providers in the lead to the operational phase of the

FMD implementation.

Moderator: Ms Leonie Clarke, Project Manager, Irish Medicines Verification Organisation (IMVO)

• Dr. Stefan Artlich, Director Track&Trace, Bayer AG

• Mr Christoph Krähenbühl, Senior Director, 3C Excellis Europe

• Mr Hitesh Varambhia, Director Life Science, EMEA, Adents

• Mr Marco Steinkamp, Sales Director Track & Trace, Movilitas Europe

11:00 COFFEE BREAK

11:30 Keynote : Falsified Medicines Directive implementation - Rallying regulatory compliance

• Ms Agnès Mathieu-Mendes, Deputy Head of Unit, Medical products: quality, safety, innovation, European

Commission DG SANTE

Falsified Medicines Directive—The final countdown

In the final stretch for the implementation of the Falsified Medicines Directive and its Delegated Regulation, our experts will provide an update on the progress made at European and national levels and what are now the

next steps to be undertaken.

Moderator: Mr Peter O’Donnell, Journalist

• Ms Agnès Mathieu-Mendes, Deputy Head of Unit, Medical products: quality, safety, innovation, European

Commission DG SANTE • Mr Andreas Walter, General Manager, European Medicines Verification Organisation (EMVO)

• Ms Monika Derecque-Pois, Director General, European Healthcare Distribution Association (GIRP)

12:45 CLOSING REMARKS

• Mr Martin FitzGerald, Deputy Director General, European Healthcare Distribution Association (GIRP)

13:00 FAREWELL LUNCH

14:30 SITE-VISIT UNITED DRUG / SSI SCHÄFER INSTALLATION

European Healthcare Distribution Association

Groupement International de la Répartition Pharmaceutique

T: +32 2 777 99 77 E: girp@girp.eu

F: +32 2 770 36 01 W: www.girp.eu